A comparison of ceramic and carbon‐based reductants for vitrification of low‐activity waste
Abstract Sucrose is the current baseline additive at the Hanford Waste Treatment and Immobilization Plant in Washington to control foaming during waste feed to glass transitions and the redox state of the glass melt. Alternative reductants are being investigated to alleviate strain on effluent treatment from toxic acetonitrile production from ...
Jessica Rigby +10 more
wiley +1 more source
In silico assessment of cellular damage from Lu-177, Ac-225, and Pb-212 therapeutic radionuclides. [PDF]
Chatzipapas KP +5 more
europepmc +1 more source
Cosmogenic radionuclides in the recently fallen Kobe (CK4) meteorite.
Kazuhisa Komura +2 more
openalex +2 more sources
Introduction Chronic venous disease (CVD) is a prevalent vascular condition that manifests through varicose veins and a variety of clinical symptoms. Lipodermatosclerosis (LDS), a severe complication of CVD, is characterized by pain, skin fibrosis, and significant impairment of the quality of life.
Yu-Ting Tsai +2 more
wiley +1 more source
National Monitoring for Radioactivity in Drinking Water - China, 2012-2024. [PDF]
Yin L, Xie Y, Qian Y, Shi C, Ji Y.
europepmc +1 more source
Hypoxia‐sensitive nitroimidazole‐functionalized pyclen derivatives were successfully synthesized and radiolabeled with 44Sc(III), affording stable and inert scandium complexes. Remarkable Sc(III)‐binding capabilities of the PC2A‐mono(amide) platform enabled excellent radiolabeling performance, with ≥92–99% yields and ≥99% radiochemical purity. MicroPET
Tibor Csupász +9 more
wiley +1 more source
Modelling single cell dosimetry and DNA damage of targeted alpha therapy using Monte-Carlo techniques. [PDF]
Jolly AL, Fielding AL.
europepmc +1 more source
The influence of cover on transportation of radionuclides from low and intermediate level radioactive waste disposal facility [PDF]
Ošep, Nejc
openalex
An overview of the role of radionuclides in targeted cancer treatment: application of biomarkers for patient selection and developments to improve treatment efficacy. [PDF]
Smith TAD.
europepmc +1 more source

